AIM ImmunoTech Inc. (AIM)
AMEX: AIM
· Real-Time Price · USD
2.52
-0.05 (-1.95%)
At close: Aug 15, 2025, 3:58 PM
2.65
5.16%
After-hours: Aug 15, 2025, 07:30 PM EDT
AIM ImmunoTech Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -17.32M | -23.93M | -28.05M | -31.12M | -28.96M | -20.77M | -19.34M | -19.29M | -19.45M | -20.9M | -18.34M | -19.37M | -19.13M | -17.21M | -16.7M | -14.17M |
Depreciation & Amortization | 246K | 240K | 230K | 249K | 238K | 350K | 325K | 274K | 256K | 280K | 428K | 577K | 775K | 773K | 731K | 579K |
Stock-Based Compensation | 686K | 551K | 271K | 241K | 243K | 344K | 569K | 794K | 954K | 1.04M | 1.08M | 1.28M | 1.57M | 1.76M | 1.7M | 1.37M |
Other Working Capital | 353K | -1.34M | 382K | 3.19M | 2.24M | 311K | -174K | 581K | 787K | 3.12M | 2.28M | 869K | 1.05M | 744K | 715K | -272K |
Other Non-Cash Items | 1.28M | -747K | -132K | -984K | -1.32M | 314K | 273K | -110K | 964K | 2.59M | 2.27M | 5.07M | 4.24M | 2.71M | 2.63M | -21K |
Deferred Income Tax | n/a | 2.3M | 1.99M | 1.66M | 1.4M | 46K | 37K | 132K | 197K | -2.53M | -2.27M | -2.33M | -2.32M | 735K | 703K | 1.17M |
Change in Working Capital | 296K | 963K | 2.51M | 7.62M | 7.13M | 2.14M | 1.26M | 1.17M | 966K | 3.74M | 2.57M | 1.09M | 895K | 158K | 330K | 726K |
Operating Cash Flow | -14.89M | -20.69M | -23.25M | -22.4M | -21.27M | -17.58M | -16.88M | -17.03M | -16.11M | -15.78M | -14.27M | -13.68M | -13.96M | -11.07M | -10.61M | -10.35M |
Capital Expenditures | -556K | -635K | -661K | -635K | -614K | -591K | -427K | -267K | -271K | -251K | -318K | -301K | -633K | -763K | -680K | -656K |
Cash Acquisitions | n/a | 47K | 231K | 237K | 266K | 219K | 335K | -7.39M | -7.42M | -7.37M | -7.59M | 371K | 736K | 965K | 886K | 641K |
Purchase of Investments | -361K | -596K | -1.04M | -1.04M | -1.59M | -2.22M | -2.17M | -2.72M | -2.72M | -22.59M | -21.7M | -22.1M | -22.54M | -3.06M | -13.12M | -9.45M |
Sales Maturities Of Investments | 5.72M | 1.97M | 1.81M | 751K | 1.3M | 1.93M | 1.97M | 10.27M | 10.08M | 30.52M | 29.39M | 20.66M | 22.29M | 2.4M | 3.16M | -2.03M |
Other Investing Acitivies | -789K | -611K | -830K | -608K | -414K | 3.32M | 3.49M | 11.22M | 10.84M | 7.28M | 7.25M | -227K | -246K | -475K | -9.97M | -13.3M |
Investing Cash Flow | 4.71M | 788K | 118K | -912K | -832K | 2.75M | 3.33M | 11.26M | 10.99M | 7.99M | 7.37M | -1.5M | -631K | -1.18M | -10.39M | -12.13M |
Debt Repayment | 2.25M | 2.5M | 2.37M | 2.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.76M | -4.85M | -5M | -5.08M | -4.69M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.3M | 2.19M | 2.19M | 147K | 147K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 6.44M | 5.55M | 5.65M | 3.21M | 485K | 338K | 130K | 180K | 80K | 205K | 210K | -4.61M | 8.19M | 11.1M | 28.23M | 43.67M |
Net Cash Flow | -3.74M | -14.35M | -17.48M | -20.1M | -21.61M | -14.49M | -13.41M | -5.59M | -5.04M | -7.59M | -6.69M | -19.78M | -6.41M | -1.15M | 7.23M | 21.18M |
Free Cash Flow | -15.44M | -21.33M | -23.91M | -23.04M | -21.88M | -18.17M | -17.3M | -17.3M | -16.38M | -16.04M | -14.59M | -13.98M | -14.6M | -11.84M | -11.29M | -11.01M |